Statistics from Altmetric.com
Competing interests ARS receives grant support from the National Institutes of Health to study the pharmacogenomics of antiplatelet agents. ARS is also a consultant for Bristol-Myers Squibb/Sanofi-aventis. AHR and JTD have no competing interests.
If you wish to reuse any or all of this article please use the link below which will take you to the Copyright Clearance Center’s RightsLink service. You will be able to get a quick price and instant permission to reuse the content in many different ways.